Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Outcomes of salvage re-irradiation in recurrent medulloblastoma correlate with age at initial diagnosis, primary risk-stratification, and molecular subgrouping.

Gupta T, Maitre M, Sastri GJ, Krishnatry R, Shirsat N, Epari S, Sahay A, Chinnaswamy G, Patil V, Shetty P, Moiyadi A.

J Neurooncol. 2019 Jun 24. doi: 10.1007/s11060-019-03225-9. [Epub ahead of print]

PMID:
31236820
2.

Craniospinal irradiation as part of re-irradiation for children with recurrent intracranial ependymoma.

Tsang DS, Murray L, Ramaswamy V, Zapotocky M, Tabori U, Bartels U, Huang A, Dirks PB, Taylor MD, Hawkins C, Bouffet E, Laperriere N.

Neuro Oncol. 2019 Mar 18;21(4):547-557. doi: 10.1093/neuonc/noy191.

PMID:
30452715
3.

Clinical, Pathological, and Molecular Characterization of Infant Medulloblastomas Treated with Sequential High-Dose Chemotherapy.

Lafay-Cousin L, Smith A, Chi SN, Wells E, Madden J, Margol A, Ramaswamy V, Finlay J, Taylor MD, Dhall G, Strother D, Kieran MW, Foreman NK, Packer RJ, Bouffet E.

Pediatr Blood Cancer. 2016 Sep;63(9):1527-34. doi: 10.1002/pbc.26042. Epub 2016 May 4. Erratum in: Pediatr Blood Cancer. 2017 Apr;64(4):.

4.

Postponed is not canceled: role of craniospinal radiation therapy in the management of recurrent infant medulloblastoma--an experience from the HIT-REZ 1997 & 2005 studies.

Müller K, Mynarek M, Zwiener I, Siegler N, Zimmermann M, Christiansen H, Budach W, Henke G, Warmuth-Metz M, Pietsch T, von Hoff K, von Bueren A, Bode U, Rutkowski S, Kortmann RD, Fleischhack G, Tippelt S.

Int J Radiat Oncol Biol Phys. 2014 Apr 1;88(5):1019-24. doi: 10.1016/j.ijrobp.2014.01.013.

PMID:
24661654
5.

Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.

Merchant TE, Kun LE, Krasin MJ, Wallace D, Chintagumpala MM, Woo SY, Ashley DM, Sexton M, Kellie SJ, Ahern V, Gajjar A.

Int J Radiat Oncol Biol Phys. 2008 Mar 1;70(3):782-7. Epub 2007 Sep 24.

6.

Patterns of Failure Following Multimodal Treatment for Medulloblastoma: Long-Term Follow-up Results at a Single Institution.

Lee DS, Cho J, Kim SH, Kim DS, Shim KW, Lyu CJ, Han JW, Suh CO.

Cancer Res Treat. 2015 Oct;47(4):879-88. doi: 10.4143/crt.2014.067. Epub 2014 Dec 8.

7.

Clinical Outcomes Among Children With Standard-Risk Medulloblastoma Treated With Proton and Photon Radiation Therapy: A Comparison of Disease Control and Overall Survival.

Eaton BR, Esiashvili N, Kim S, Weyman EA, Thornton LT, Mazewski C, MacDonald T, Ebb D, MacDonald SM, Tarbell NJ, Yock TI.

Int J Radiat Oncol Biol Phys. 2016 Jan 1;94(1):133-138. doi: 10.1016/j.ijrobp.2015.09.014. Epub 2015 Sep 18.

8.

Reirradiation for Recurrent Pediatric Central Nervous System Malignancies: A Multi-institutional Review.

Rao AD, Rashid AS, Chen Q, Villar RC, Kobyzeva D, Nilsson K, Dieckmann K, Nechesnyuk A, Ermoian R, Alcorn S, MacDonald SM, Ladra MM, Ford EC, Winey BA, Figueiredo MLS, Chen MJ, Terezakis SA.

Int J Radiat Oncol Biol Phys. 2017 Nov 1;99(3):634-641. doi: 10.1016/j.ijrobp.2017.07.026. Epub 2017 Jul 29.

PMID:
29280457
9.

Feasibility and outcome of re-irradiation in the treatment of multiply recurrent pituitary adenomas.

Verma J, McCutcheon IE, Waguespack SG, Mahajan A.

Pituitary. 2014 Dec;17(6):539-45. doi: 10.1007/s11102-013-0541-x.

PMID:
24272035
10.

Salvage treatment for recurrent intracranial germinoma after reduced-volume radiotherapy: a single-institution experience and review of the literature.

Hu YW, Huang PI, Wong TT, Ho DM, Chang KP, Guo WY, Chang FC, Shiau CY, Liang ML, Lee YY, Chen HH, Yen SH, Chen YW.

Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):639-47. doi: 10.1016/j.ijrobp.2011.12.052. Epub 2012 Feb 21. Review.

PMID:
22361082
11.

Salvage craniospinal irradiation with an intensity modulated radiotherapy technique for patients with disseminated neuraxis disease.

Wei RL, Nguyen ST, Yang JN, Wolff J, Mahajan A.

Pract Radiat Oncol. 2012 Oct-Dec;2(4):e69-e75. doi: 10.1016/j.prro.2012.01.004. Epub 2012 Feb 16.

PMID:
24674188
12.

Postoperative radiation therapy for medulloblastoma--high recurrence rate in the subfrontal region.

Sun LM, Yeh SA, Wang CJ, Huang EY, Chen HC, Hsu HC, Lee SP.

J Neurooncol. 2002 May;58(1):77-85.

PMID:
12160144
13.

Re-Irradiation for Recurrent Gliomas: Treatment Outcomes and Prognostic Factors.

Lee J, Cho J, Chang JH, Suh CO.

Yonsei Med J. 2016 Jul;57(4):824-30. doi: 10.3349/ymj.2016.57.4.824.

14.

Multivariate analysis of dissemination relapse of medulloblastoma and estimation of its time parameter for craniospinal irradiation.

Inakoshi H, Kayamori R, Tsuchida E, Sakai K, Shibamoto Y, Wakushima H, Ogawa Y, Kobayashi M, Obara T.

Radiat Med. 2003 Jan-Feb;21(1):37-45.

PMID:
12801142
15.

Re-irradiation Using Intensity-modulated Radiotherapy for Recurrent and Second Primary Head and Neck Cancer.

Choi SH, Chang JS, Choi J, Park SH, Keum KC, Park KR, Lee CG.

Anticancer Res. 2018 May;38(5):3165-3173.

PMID:
29715158
16.

Evaluation of particle radiotherapy for the re-irradiation of recurrent intracranial meningioma.

El Shafie RA, Czech M, Kessel KA, Habermehl D, Weber D, Rieken S, Bougatf N, Jäkel O, Debus J, Combs SE.

Radiat Oncol. 2018 May 8;13(1):86. doi: 10.1186/s13014-018-1026-x.

17.
18.

Concurrent hyperthermia and re-irradiation for recurrent high-grade gliomas.

Heo J, Kim SH, Oh YT, Chun M, Noh OK.

Neoplasma. 2017;64(5):803-808. doi: 10.4149/neo_2017_520.

PMID:
28592133
19.

Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutions.

Wild AT, Hiniker SM, Chang DT, Tran PT, Khashab MA, Limaye MR, Laheru DA, Le DT, Kumar R, Pai JS, Hargens B, Sharabi AB, Shin EJ, Zheng L, Pawlik TM, Wolfgang CL, Koong AC, Herman JM.

J Gastrointest Oncol. 2013 Dec;4(4):343-51. doi: 10.3978/j.issn.2078-6891.2013.044.

20.

Reirradiation for Recurrent Nasopharyngeal Carcinomas: Experience From an Academic Tertiary Center in a Low- to Middle-Income Country.

Agas RAF, Yu KKL, Sogono PG, Co LBA, Jacinto JCKM, Bacorro WR, Mejia MBA.

J Glob Oncol. 2019 Feb;5:1-14. doi: 10.1200/JGO.18.00191.

Supplemental Content

Support Center